Literature DB >> 9512525

Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.

R V Giles1, D G Spiller, J Grzybowski, R E Clark, P Nicklin, D M Tidd.   

Abstract

It is widely accepted that most cell types efficiently exclude oligonucleotides in vitro and require specific delivery systems, such as cationic lipids, to enhance uptake and subsequent antisense effects. Oligonucleotides are not readily transfected into leukaemia cell lines using cationic lipid systems and streptolysin O (SLO) is used to effect their delivery. We wished to investigate the optimal oligonucleotide composition for antisense efficacy and specificity following delivery into leukaemia cells using SLO. For this study the well characterised chronic myeloid leukaemia cell line KYO-1 was selected and oligonucleotides (20mers) were targeted to an empirically identified accessible site of c- myc mRNA. The efficiency and specificity of antisense effect was measured 4 and 24 h after SLO-mediated delivery of the oligonucleotides. C5-propyne phosphodiester and phosphorothioate compounds were found to present substantial non-specific effects at 20 microM but were inactive at 0.2 microM. Indeed, no antisense-specific effect was noted at any concentration at either time. All of the other oligonucleotides tested induced some measurable antisense effect, except 7 (chimeric, all-phosphorothioate, 2'-methoxyethoxy termini) which was essentially inactive at 20 microM. The rank efficiency order of the remaining antisense compounds was 4 = 3 >> 9 >> 10 = 8 = 5 = 6 > 11. The efficient antisense effects induced by the chimeric methylphosphonate-phosphodiester compounds were found to be highly specific. Increased phosphorothioate content in the oligonucleotide backbone correlated with reduced antisense activity (efficacy: 2'-methoxyethoxy series 9 >> 8 >> 7, 2'-methoxytriethoxy series 10 > 11). No consistent evidence was obtained for increased activity correlating with increased oligonucleotide-mRNA heteroduplex thermal stability. In conclusion, the chimeric methylphosphonate-phosphodiester oligodeoxynucleotides present the most favourable characteristics of the compounds tested, for efficient and specific antisense suppression of gene expression following SLO-mediated delivery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512525      PMCID: PMC147466          DOI: 10.1093/nar/26.7.1567

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  BCR-ABL and BCR proteins: biochemical characterization and localization.

Authors:  S Dhut; T Chaplin; B D Young
Journal:  Leukemia       Date:  1990-11       Impact factor: 11.528

2.  Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors:  R V Giles; D M Tidd
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  The uptake kinetics of chimeric oligodeoxynucleotide analogues in human leukaemia MOLT-4 cells.

Authors:  D G Spiller; D M Tidd
Journal:  Anticancer Drug Des       Date:  1992-04

4.  Non-radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG); hybridization and ELISA-based detection.

Authors:  H J Höltke; C Kessler
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

5.  Characterization of oligonucleotide transport into living cells.

Authors:  S L Loke; C A Stein; X H Zhang; K Mori; M Nakanishi; C Subasinghe; J S Cohen; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages.

Authors:  Y Shoji; S Akhtar; A Periasamy; B Herman; R L Juliano
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

7.  Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.

Authors:  T Skórski; C Szczylik; L Malaguarnera; B Calabretta
Journal:  Folia Histochem Cytobiol       Date:  1991       Impact factor: 1.698

8.  Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides.

Authors:  C Szczylik; T Skorski; N C Nicolaides; L Manzella; L Malaguarnera; D Venturelli; A M Gewirtz; B Calabretta
Journal:  Science       Date:  1991-08-02       Impact factor: 47.728

9.  Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.

Authors:  R V Giles; D M Tidd
Journal:  Anticancer Drug Des       Date:  1992-02

10.  Potent and selective inhibition of gene expression by an antisense heptanucleotide.

Authors:  R W Wagner; M D Matteucci; D Grant; T Huang; B C Froehler
Journal:  Nat Biotechnol       Date:  1996-07       Impact factor: 54.908

View more
  22 in total

1.  The many ways to cross the plasma membrane.

Authors:  D J Stephens; R Pepperkok
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Dynamics of native β-actin mRNA transport in the cytoplasm.

Authors:  Aaron W Lifland; Chiara Zurla; Joana Yu; Philip J Santangelo
Journal:  Traffic       Date:  2011-05-18       Impact factor: 6.215

3.  Probes for intracellular RNA imaging in live cells.

Authors:  Philip J Santangelo; Eric Alonas; Jeenah Jung; Aaron W Lifland; Chiara Zurla
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

4.  Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin.

Authors:  Christopher M Pirie; David V Liu; K Dane Wittrup
Journal:  Mol Cancer Ther       Date:  2013-07-05       Impact factor: 6.261

5.  The high binding affinity of phosphorothioate-modified oligomers for Ff gene 5 protein is moderated by the addition of C-5 propyne or 2'-O-methyl modifications.

Authors:  Tung-Chung Mou; Donald M Gray
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

6.  Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O.

Authors:  I Walev; S C Bhakdi; F Hofmann; N Djonder; A Valeva; K Aktories; S Bhakdi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

7.  Oligodeoxynucleotide 5mers containing a 5'-CpG induce apoptosis through a mitochondrial mechanism in T lymphocytic leukaemia cells.

Authors:  D M Tidd; D G Spiller; C M Broughton; L C Norbury; R E Clark; R V Giles
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

8.  Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzyme.

Authors:  Y Hamel; J Lacoste; C Frayssinet; A Sarasin; T Garestier; J C François; C Hélène
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

9.  NANOSTRUCTURED PROBES FOR IN VIVO GENE DETECTION.

Authors:  Gang Bao; Phillip Santangelo; Nitin Nitin; Won Jong Rhee
Journal:  Nanomedicine (Chichester)       Date:  2010

Review 10.  Fluorescent probes for live-cell RNA detection.

Authors:  Gang Bao; Won Jong Rhee; Andrew Tsourkas
Journal:  Annu Rev Biomed Eng       Date:  2009       Impact factor: 9.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.